New drug may stop bleeding after heart surgery better than standard care
NCT ID NCT07032792
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two treatments for bleeding after heart surgery: FEIBA (a special clotting medicine) and fresh frozen plasma (standard care). About 140 adults having non-emergency heart surgery will be enrolled. The goal is to see if FEIBA reduces the need for blood transfusions more effectively than the standard approach.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLEEDING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
North Shore University Hospital
RECRUITINGManhasset, New York, 11030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a hot bath after exercise help heal the heart?
- Brain-Tracking anesthesia: a faster, smoother Wake-Up?
- Can robots make pediatric surgery safer? a new registry aims to find out
- Can big data reveal the true risks of lung surgery?
- Can a gas added to Heart-Lung machines shield Newborns' kidneys?
- Can surgery for a bowel disorder also lift depression and anxiety?